July 20, 2025PLoS ONEOpen Access

Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024)

View Full Paper

Ask AI

Bookmark

Glycemic control, particularly stringent control, may lower unfavorable TB treatment outcomes in people with TB-DM.
One high-quality study suggested that HbA1c < 7% at baseline significantly reduces recurrence risk compared to poor control.
The review included 14 studies, highlighting the need for randomized controlled trials to clarify insulin's role in TB treatment outcomes.
Clinical and methodological heterogeneity among studies prevented a meta-analysis and emphasizes the need for standardized research methods.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review indicates glycemic control and insulin use may influence TB treatment outcomes in those with TB-DM, highlighting a need for more research.

Cite This Study

Shewade et al. (2025) studied this question.

synapsesocial.com/papers/689a02c9e6551bb0af8ccf8d https://doi.org/10.1371/journal.pone.0328619

View Full Paper

Ask AI

Bookmark

Implication

Systematic review indicates glycemic control and insulin use may influence TB treatment outcomes in those with TB-DM, highlighting a need for more research.

Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024)

Key Points

Discussion

Implication

Cite This Study

Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024)

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading